Press Releases

ROCHESTER, NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Syntec Optics (NASDAQ:OPTX), a leading provider of mission-critical optics for defense tech, space tech, and AI data centers, today announced that the company more than doubled its purchase orders—worth over $9 million—to supply defense equipment, up from its Q1 announcement about orders for diverse defense platforms. Orders for optics that help guide missiles to hit targets accurately grew an additional 30% since the last announcement of a 40% increase. On another front, Syntec continued to add orders for optics and optics-mechanicals used in equipment that helps soldiers see clearly in the dark and spot targets day or night. Orders

Demonstrating Sands China's long-term commitment to investing in Continuously expanding non-gaming offerings to support Macao's economic diversificationMACAO, Sept. 10, 2026 /PRNewswire/ -- The Parisian® Macao will mark its 10th anniversary on Sept. 13. Over the past decade, the integrated resort has not only evolved into a landmark on the Cotai Strip, but has also demonstrated Sands China's steadfast confidence in Macao's long-term growth, as well as its enduring commitment to expanding non-gaming elements, supporting the Macao's economic diversification and its status as World Centre of Tourism and Leisure. Since its inception, The Parisian Macao has attracted more than 100 million visitor

COLUMBUS, Ohio, Sept. 10, 2026 /PRNewswire/ -- M/I Homes, Inc. (NYSE:MHO) announces the following Webcast: What: M/I Homes, Inc. Announces Third Quarter WebcastWhen:             October 21, 2026 @ 10:30AM Eastern TimeWhere:           http://www.mihomes.comHow:               Live over the Internet -- Simply log on to the web at the address above Contact:Ann Marie Hunker, Vice President, Chief Accounting Officer, Controller of M/I Homes, Inc.,      amhunker@mihomes.com, or 614-418-8225Mark Kirkendall, Vice President, Treasurer of M/I Homes, Inc.,      mkirkendall@mihomes.com, or 614-418-8021    If you are unable to participate du

New 2-week reusable contact lens brings advanced ACUVUE OASYS MAX technologies to deliver superior comfort and visual clarity to patients, even at day 14*†1 Expands the ACUVUE OASYS MAX portfolio with an advanced option for reusable contact lens wearers Designed to meet the growing demand for lasting comfort and clear vision in today’s screen-intensive world *†1 Johnson & Johnson (NYSE:JNJ) today announced that it has received CE Marking for ACUVUE OASYS MAX 2-Week,*** a new reusable contact lens featuring proprietary MAX technologies designed to deliver superior comfort and visual clarity, even at day 14.*†i¥1 The lens will be rolled out in select European countries later this ye

New Bobtail Expected to Generate Approximately AED 400,000 to AED 500,000 ($109,000 to $136,000) in Monthly Revenue Upon Reaching Target Delivery Volume Al Shola Gas Expands Fleet to 53 Vehicles, Including Three LPG Bobtails, with Fourth Bobtail on Order to Support Further Distribution Growth New Dubai Supreme Council of Energy Petroleum Products Permit Strengthens Al Shola Gas’s Competitive Position in Dubai’s LPG Market Dublin, Ireland, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Fusion Fuel Green PLC (NASDAQ:HTOO) ("Fusion Fuel" or the "Company"), a diversified energy platform, today announced that its indirect subsidiary, Al Shola Al Modea Gas Distribution L.L.C. ("Al Shola Gas"), an industr

SANTA ANA, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ:TTMI) ("TTM") announced today that it intends to offer, subject to market and other customary conditions, $500 million in aggregate principal amount of senior notes due 2034 (the "Notes") in a private offering exempt from registration under the Securities Act of 1933, as amended (the "Securities Act"). The Notes will be senior unsecured obligations of TTM and will be guaranteed by TTM’s subsidiaries that guarantee its senior secured credit facilities, including its term loan B due 2030 and its revolving credit facility (the "Revolving Credit Facility"), subject to certain exceptions. TTM intends to use th

Authorization from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) builds on CAMP4’s recent clearances to initiate first-in-human studies for CMP-002 in Australia and Argentina Company anticipates initiation of the clinical trial in 4Q 2026 WATERTOWN, Mass., Sept. 10, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4" or "the Company") (NASDAQ:CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced the company has received authorization from the United

In the Past 5 Years Deako Has Shipped Over 32 million Units of Its Technologies Including Its Smart Home Plug-In Wall Switches, with Over $26M in Revenues in 2025  Deako is a Leading Technology Supplier to Over 50 U.S. Builders Including D.R. Horton, Toll Brothers, Risewell Homes, Adams Homes, Maronda Homes, Shea Homes, Schumacher Homes, Among Others, and is Expected to Fast Track SKYX’s Technologies to the Vast Builder Market Deako’s Lead Investor and Board Member, Include Paul Jacobs, former Chairman and CEO of Qualcomm, and Board Member Marwan Fawaz, former CEO of Nest SKYX and Deako Management will Hold a Conference Call Today, September 10, 2026, at 8:30 a.m. Eastern Time, to Discu

Current Visibility into Over $1.9 Billion of 2026 Investment VolumeImproved Outlook for 2026 Tenant Credit-Related Rent LossNEW YORK, Sept. 10, 2026 /PRNewswire/ -- W. P. Carey Inc. (W. P. Carey, NYSE: WPC), a leading net lease REIT specializing in corporate sale-leasebacks, build-to-suits and the acquisition of single-tenant net lease properties, today provided a business update regarding investment activity and its outlook for tenant credit-related rent loss.Investment Activity W. P. Carey currently has visibility into investment volume totaling more than $1.9 billion for full-year 2026, including approximately $1.4 billion of investment volume completed year to date, transactions in its p

Dani Reiss, Chair of the Board of Directors and Chief Executive Officer of Canada Goose Holdings Inc. (NYSE:GOOS, TSX:GOOS) ("Canada Goose"), is pleased to announce that on September 9, 2026, through DTR LLC ("DTR"), his investment holding company, he acquired an aggregate of 100,000 subordinate voting shares ("SVS") of Canada Goose through open market purchases on the Toronto Stock Exchange ("TSX") and other Canadian published markets.The acquisition increases Mr. Reiss’ ownership position in Canada Goose and reflects his continued long-term investment in the Company.Immediately prior to the acquisition reported hereby, Mr. Reiss beneficially owned and exercised control and direction over 1

Agenus Inc. (NASDAQ:AGEN), a leader in immuno-oncology innovation, today announced that a poster evaluating botensilimab (BOT), an Fc-enhanced multifunctional anti-CTLA-4 antibody, in combination with balstilimab (BAL), an anti-PD-1 antibody, has been accepted for presentation at the International Gynecologic Cancer Society (IGCS) Annual Global Meeting, taking place October 1–3, 2026, in Montreal, Canada. The presentation will feature results from the recurrent ovarian cancer cohort of the large Phase 1b C-800-01 study, including patients with platinum-refractory/resistant disease, with analyses by platinum sensitivity status and long-term three-year overall survival. Presentation Detai

PHILADELPHIA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided, biotech/life sciences company focused on advancing novel and potentially disruptive therapeutic assets, today announced that an abridged Clinical Study Report (CSR) for SKNJCT-003 (NCT06608238) has been posted on ClinicalTrials.gov, providing transparent public access to the efficacy, safety, drug-delivery and clinical findings from the completed Phase 2 study.  Publication of the abridged CSR represents an important scientific milestone for SkinJect® and provides a transparent public record of the completed Phase 2 findings. The Company believes the dataset

Court Holds ATG Capital's Nomination Notice Valid and That Its Nominees Will Stand for Election at the October 14 Annual Meeting ATG Capital Streamlines Its Slate to Four Director Nominees to Ensure Independent Oversight Without Disrupting the Company's Operational Pivot Urges Stockholders to Vote "FOR" All Four ATG Capital Nominees on the Gold Proxy Card MIAMI, Sept. 10, 2026 (GLOBE NEWSWIRE) -- ATG Capital Management LP ("ATG Capital"), together with certain of its affiliates, the beneficial owner of approximately 16% of the outstanding shares of Empery Digital Inc. (NASDAQ:EMPD) ("Empery" or the "Company"), today commented on the August 28, 2026 ruling of the Delaware Court of Chance

MasterCraft Boat Holdings, Inc. (NASDAQ:MCFT) today announced financial results for its fiscal 2026 fourth quarter and year ended June 30, 2026. The overview, commentary, and results provided herein relate to our continuing operations, which consists of our Performance and Wake, Leisure, and Recreation and Sport Fishing segments. Performance and Wake was formerly reported as MasterCraft, Leisure was formerly reported as Pontoon, and Recreation and Sport Fishing was established following the combination with Marine Products Corporation ("Marine Products"), as discussed below. On May 15, 2026, the Company completed the merger with Marine Products ("Marine Products Transaction"). As a resu

- Expands on previously reported findings in which 84% of evaluable first-line PDAC patients treated with atebimetinib + mGnP maintained or gained weight at three months - - New analyses evaluate the overall survival implications of both preserving body mass and reducing tumor volume - NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (NASDAQ:IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced it will present a poster at the American Association for Cancer Research (AACR) Conference on Pancreatic Cancer: New Frontiers in Biology and Therapeutic Development taking place September 25-28, 2026, in

NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the H.C. Wainwright 28th Annual Global Investment Conference, being held on September 14 - 16, 2026. The fireside chat is scheduled to take place on Monday, September 14, 2026, at 12:00pm ET. A live webcast of the fireside chat will be available on the Events page, located within the Investors & Media section, of the Company’s website at http://ir.tgtherapeutics.com/events. ABOUT TG THERAPEUTICSTG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition,

NEW YORK and TORONTO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Helus Pharma (NASDAQ:HELP) (Cboe CA: HELP) (the "Company" or "Helus Pharma"), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists ("NSAs"), today announced that Michael Halstead, Helus Pharma’s Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference in New York City. The fireside chat will be webcast live on Wednesday, September 16, 2026 at 8:30 a.m. EDT. To register for the webcast, click here. A replay will be available on the Events & Presentations page of Helus Pharma’s investor relations website. A

PANAMA CITY, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Copa Holdings, S.A. (NYSE:CPA) today released preliminary passenger traffic statistics for August 2026: Copa Holdings (Consolidated)August2026August2025% ChangeASM (mm)(1)3,219.1 2,755.1 16.8% RPM (mm)(2)2,840.9 2,432.2 16.8% Load Factor(3)88.3% 88.3% —p.p.         Available seat miles - represents the aircraft seating capacity multiplied by the number of miles the seats are flown.Revenue passenger miles - represents the number of miles flown by revenue passengersLoad factor - represents the percentage of aircraft seating capacity that is utilized For August 2026, Copa Holdings' capacity (ASMs) increased by 16.8%, while system-wide passenge

GUANGZHOU, China, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next-generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months ended June 30, 2026. Recent Business Updates Therapy Selection & MRD OncoScreen® BCMatch Tissue Kit has officially entered the Priority Review Channel of the Center for Medical Device Evaluation (CMDE) under the NMPA.CanCatch Custom Kit and CanCatch Custom Kit (cPAS) have officially entered the Special Review Procedure for Innovative Medical Devices of CMDE under the NMPA.In August 2026, t

MasTec, Inc. (NYSE:MTZ) today announced the appointment of Ati Modak as Vice President of Investor Relations, effective September 2026. Mr. Modak joins MasTec from Goldman Sachs, where he served as Vice President, Equity Research, Energy Services, covering companies across the traditional and new energy sectors. Prior to joining Goldman Sachs in 2019, he worked at Citi. Mr. Modak received his Bachelor of Engineering degree from PDEU in India and his M.B.A. from Fordham University in New York. José Mas, MasTec's Chief Executive Officer, noted, "We are pleased to welcome Ati to MasTec family. He brings a unique combination of deep knowledge of the infrastructure services sector, familiari